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Katz et al.  (1) have demonstrated a restriction in lymphoid cell interaction when the 
antigen used is under immune response (Ir) gene control. T cells from (low responder × 
high responder) F1 mice primed to the terpolymer L-glutamic acid, L-lysine,  L-tyrosine 
(GLT)  can  collaborate  with  2,4-dinitrophenyl  (DNP)-primed  B  cells  from the Ir-GLT 
high responder but not low responder strain in response to DNP-GLT (1). In contrast 
are the studies of Bechtol et al.  and Bechtol and McDevitt (2,  3),  who examined the 
antibody  responses  of tetraparental  mice  immunized  with  the  synthetic  polypeptide 
poly-L(Tyr,Glu)-poly D,L-Ala--POly-L-Lys ((T,G)-A-L), an antigen under Ir-lA  genetic 
control. Several tetraparental mice produced anti-(T,G)-A-L antibody of low responder 
strain immunoglobulin (Ig) allotype (2, 3). These results indicated that the Ir-lA  gene 
was not expressed in B cells and implied that interactions among genetically dissimilar 
cell populations could occur when tolerance existed to H-2 antigenic differences. Recent 
studies  with  bone marrow cell  chimeric mice have  shown that  chimeric T  cells  can 
interact with H-2  histoincompatible B cells in response to antigens not under Ir gene 
control (4-6). 
To clarify whether lymphoid cell chimerism, with presumed tolerance to H-2 
incompatibility, would permit effective cell interactions in response to antigens 
under Ir gene control, bone marrow cell chimeric mice were prepared by using 
strains differing both for Ig allotype and for high versus low responsiveness to 
(T,G)-A-L. An antigen-specific and allotype-specific antibody assay was used 
to  discriminate  the  responses  produced  by  high  and  low  responder  strain  B 
cells in these chimeras.  The results suggest that lymphoid cell chimerism per 
se is not sufficient to obviate Ir gene-mediated restrictions in cell interaction. 
Materials and Methods 
Animals, Immunization.  C3H.SW (CSW, H-2 ~, Ig~), CWB (H-2 b, Igb), CKB (H-2 k, Igb), C3H/ 
DiSn (H-2 ~, Ig~),  (CSW × C3H)F~, and (CKB x CSW)Fj congenic mice were obtained from the 
breeding colonies maintained  at Stanford University.  CKB ,~ CSW bone marrow cell chimeric 
mice were prepared by the method of von Boehmer et al. (4). 8 wk old (CSW × C3H)F~ mice were 
irradiated  with 800 rads from a 250 kV, 15 mA Phillips X-ray generater. Bone marrow cells were 
flushed from the femurs of CKB and CSW,  adult mice by using Dulbecco's  phosphate-buffered saline 
(PBS) containing 5% fetal calf serum (FCS). T cells were eliminated by incubating 108 bone marrow 
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cells with 1 ml of a 1:5 dilution ofAKR anti-C3H (anti-Thy 1.2) thymecyte serum in PBS-FCS for 25 
rain at 4°C. The anti-Thy 1.2-treated bone marrow cells were washed and incubated in 3 ml of a 1:8- 
1:12 dilution of agarose  absorbed rabbit complement in Dulbecco's modified Eagles medium for 45 
rain at 37°C. Irradiated (CSW x C3H)F~ mice were injected with 5 x  l0  s washed bone marrow cells 
from each donor (CKB,  CSW) i.v.  8  wk later, these CKB ~-~ CSW chimeric mice were bled for 
preimmune sera, then immunized i.p. with 10/~g of (T,G)-A-L-52 in complete Freund's adjuvant. 
As controls, 8 to 12-wk old CKB, CSW, and (CKB x CSW)F1  mice were also immunized. 1 mo after 
priming, a secondary challenge of 10 ~g of (T,G)-A-L-52 was administered i.p. in PBS, and the 
mice were bled for secondary sera 8 days later. 
Allotype-Specific  Radioimmunoassay  for Anti-(T,G)-A-L  Antibody.  A  modification of the 
antigen-specific plate radioimmunoassay described  by Klinman et al.  (7) was used to measure 
serum anti-(T,G)-A-  L antibodies. The wells of flexible plastic microtiter plates (Scientific Products 
Inc.) were coated with 20 ~1 of (T,G)-A-  L-52 at a concentration of 0.05 mg/ml in PBS. This anti- 
gen concentration was sufficient to saturate the wells for antigen, since higher concentrations 
did not alter the antibody binding  curves. After incubation  with antigen for 2 h at room tempera- 
ture,  the  antigen-coated plates were  washed twice  with  PBS  containing 5%  agamma horse 
serum (PBS-HS). The wells were then incubated with 20 /~l of serum dilutions prepared in PBS 
containing 1% bovine serum albumin (PBS-BSA) for 3 h  at room  temperature, washed twice 
with cold PBS-HS, and incubated overnight at 4°C with 20 ~1 per well of the 125I-labeled  detecting 
reagent (anti-allotype antibody). 
After washing the plates four times with cold PBS-HS, the wells were cut out of the plates and 
counted  individually in a  gamma counter for 0.4 or  1.0 min. Variation in duplicate ~I-counts 
bound generally did not exceed 15%. 
Allotype-specific, l~I-labeled mouse antibodies against Ig-1 a (IgG2a),  Ig-1 b (IgG2a), lg-4 ~ (IgG~), 
and Ig-4 b (IgG1) Ig allotypes were prepared and generously provided by Dr. Len Herzenberg, Mr. 
Vernon Oi, and Mr. Derek Hewgill (Stanford University School of Medicine) who have described 
the methodology  for the preparation of these reagents in a  separate communication (8). The 
specificity of Ig allotype detection with these reagents was analyzed in the (T,G)-A-L-specific 
antibody binding  assay, and the results are described below. Pooled secondary sera from CSW and 
CWB mice immunized with (T,G)-A-L-509, which have been used routinely in this laboratory 
as standards for antibody analysis by a modified  Farr assay (2, 3) were used as the source of 
standard anti-(T,G)-A-L antibodies for the allotype-mixing studies described below. 
Results 
An analysis of the Ig allotype-specific detection of anti-(T,G)-A-L  antibodies 
in mixtures of CSW (Ig a) and CWB (Igb), and mixtures of CSW and CKB (Ig b) 
secondary sera, is shown in Table I. CSW and CWB mice, both H-2 b,  are high- 
responders to  (T,G,)-A-L,  whereas CKB mice (H-2 k)  are low-responders. The 
100%  Ig  a  (CSW)  and  100%  Ig  b  (CWB,  CKB)  columns represent  the  counts 
bound of the four iodinated anti-allotype reagents, beginning with a  hl00 anti- 
(T,G)-A-L  serum dilution, with doubling dilutions thereafter.  The 12SI-labeled 
anti-Ig  b  allotype  antibodies  do  not  bind  significantly to  (T,G)-A-L-specific 
antibodies from CSW (Ig a) mice, nor do the iodinated anti-Ig  a allotype antibod- 
ies  bind  to  Ig  b  allotype  anti-(T,G)-A-L  antibodies  from  either  the  high- 
responder (CWB) or low-responder (CKB) mice. There is a  quantitative differ- 
ence in the amount of anti-(T,G)-A-L  antibody produced by CWB versus CKB 
mice,  in both  the  IgG1  (Ig-4  b)  and IgG2a  (Ig-1 b)  class.  The  values in Table I 
obtained for the binding and detection of 100% Ig  a  (CSW) and 100% Ig  ~ (CWB) 
allotype  anti-(T,G)-A-L  antibodies  can  also  be  plotted  as  standard  curves, 
such that 20 pl of a  1:100 antiserum dilution is designated 20  ×  10  -2 ~tl, a  1:200 
dilution is 10  ×  10  -2 ~l,  and so forth,  versus ~25I-anti-allotype-counts  bound. A 
linear  correlation  is  then  observed  between  iodinated  anti-allotype  counts 
bound and antibody concentration at high serum dilutions, where the detecting PRESS  AND  McDEVITT  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Allotypic Detection of Anti-(T,G)-A-L Antibody in Serum Mixures* 
1817 
100%Ig  a  100%Ig  ~ 100%Ig  b  20~Ig~/80%Ig ~  40%Iga/60%Ig  b  60%Ig°140%Ig  ~  80%Iga/20%Ig  ~ 
~l-de-  Logs se- 
tscting  rum dilu-  CSW+  CSW+  CSW+  CSW+  CSW+  CSW+  CSW+  CSW+ 
reagentS  tion§  CSW  CWB  CKB  CWB  CKB  CWB  CKB  CWB  CKB  CWB  CKB 
Anti-Ig4  a  1  2,107  124  79  1,732  1,807  1,914  1,847  1,895  1,8~  1,886  2,027 
2  1,846  91  78  1,595  1,686  1,972  1,883  1,906  1,897  1,747  1,838 
3  1,774  95  94  1,382  1,383  1,645  1,656  1,680  1,836  1,778  1,757 
4  1,821  90  67  996  873  1,478  1,467  1,627  1,584  1,727  1,739 
5  1,472  88  72  631  589  990  894  1,305  1,193  1,517  1,446 
6  1,171  67  73  395  342  614  593  814  778  1,035  913 
7  776  106  66  213  239  388  375  520  554  672  609 
8  548  66  87  188  193  315  258  353  332  471  452 
Anti-Ig-4 ~ 
Anti-Ig.1 a 
Anti-Ig-I  ~ 
1  194  3,213  706  3,257  668  3,213  552  3,024  384  2,797  319 
2  172  3,044  361  3,004  417  2,966  347  2,704  291  2,522  261 
3  112  2,999  237  2,873  255  2,594  244  2,374  190  1,861  173 
4  101  2,612  167  2,498  152  2,180  120  1,835  102  1,246  116 
5  55  2,016  89  1,749  114  1,372  87  1,040  108  G64  84 
6  56  1,260  82  1,070  96  850  74  589  71  385  64 
7  53  791  77  670  74  505  75  343  58  205  64 
8  52  490  49  450  54  340  58  233  61  181  58 
1  11,851  126  101  4,588  4,775  7,202  7,544  9,187  8,906  9,847  10,389 
2  8,013  80  61  2,848  2,842  4,434  4,605  5,961  5,835  6,745  6,863 
3  5,620  86  50  1,724  1,603  2,999  3,013  3,861  3,700  4,627  4,213 
4  3,604  74  87  1,026  1,025  1,745  1,607  2,406  2,260  2,716  2,687 
5  2,123  75  73  666  641  1,020  1,025  1,434  1,313  1,779  1,747 
6  1,358  90  69  428  409  741  643  949  880  1,107  1,016 
7  889  61  62  297  272  469  474  609  595  669  688 
8  621  87  77  218  215  353  381  479  447  583  508 
1  98  9,854  1,278  8,467  1,655  7,094  1,604  4,930  1,172  3,350  634 
2  161  6,358  742  5,269  787  4,147  851  2,921  700  1,950  349 
3  108  3,703  373  3,095  403  2,529  405  1,559  319  1,052  246 
4  99  2,187  279  1,919  252  1,344  233  974  224  671  147 
5  102  1,200  162  1,256  173  745  141  572  148  323  113 
6  77  695  108  613  132  434  104  327  84  249  80 
7  72  426  105  371  104  277  87  228  90  155  64 
8  80  322  108  264  90  212  104  172  88  148  82 
* A I:I(X}  dilution of secondary  CSW anti-(T,G)-A-  L-509 serum was mixed with 1:106 dilution of either CWB or CKB anti~(T,G)-A- 
L serum to give allotype ratios indicated. 
20 ~  of detasting reagent added per assay: anti-Ig-4% 20136 counts,  antio]g-4 b, 20,986 counts,  anti-Ig-1 ° , 18,171 counts,  and anti-Ig- 
1  ~, 19,931 c~unts,  all per 0.4 rain. 
§ First serum dilution is 1:100; doubling dilutions thereatter. 
reagent  is  in  excess.  Saturated  (plateau)  conditions  are  observed  at  lower 
serum dilutions (e.g. 1:100) (curves not shown). 
Table  I  also  demonstrates that  in  mixtures of anti-(T,G)-A-L antibodies 
from  two  high-responder  strains  differing  in  Ig  allotypes  (CSW  +  CWB 
mixtures), the Ig  a and Ig  b allotype antibodies can be clearly distinguished. The 
binding of Ig  b allotype anti-(T,G)-A-L antibody does not appear to interfere 
with or displace the binding of Ig  a allotype antibody. This is seen most clearly 
by  comparing  the  counts  bound  by  either  anti-Ig-1  a  or  anti-Ig-4  ~  allotype 
antibody in the mixtures (CSW +  CWB) versus (CSW +  CKB). For example, 
at a  1:100 dilution of total serum antibody in a 20% Iga/80% Ig  b mixture, there 
are 1,732 counts of anti-Ig-4  ~ bound for (CSW +  CWB), and 1,807 counts bound 
for (CSW +  CKB). 
The binding of Ig  a allotype anti-(T,G)-A-L antibody to the antigen-coated 
plate can thus be detected in the presence of binding by Ig  b allotype antibody. 1818  PRESS  AND  McDEVITT  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Analysis of Anti-(T,G)-A -L Antibody Produced by Chimeric Mice 
Serum 
dilu-  ~2H-labelodanti-allotype  Production of 
reagents§  LR allotyp~l 
tion$ 
Donor* 
Log~ 
Anti-  Anti.  Anti-  Anti- 
1 .  1 ~  4 ~  4 ~ 
CKB  ~  CSW 
Chimeras 
No. 1  1  276  148  206  51 
2  168  184  148  57 
3  148  144  154  56 
4  98  145  144  69 
No. 2  1  1,604  168  781  140 
2  870  186  488  111 
3  517  159  282  65 
4  306  202  210  73 
No. 3  1  2,174  232  777  77 
2  1,197  168  409  48 
3  649  184  275  57 
4  469  142  247  57 
No. 4  1  2,129  214  1,860  116 
2  1,247  197  1,530  66 
3  679  182  1,049  81 
4  446  155  548  49 
No. 5  1  983  246  1,030  71 
2  556  206  593  74 
3  343  202  355  65 
4  230  170  311  47 
CKB  x  CSW  F~ 
No.  1  1  379  661  237  1,185 
2  239  395  145  660 
3  152  254  127  370 
4  158  246  109  247 
Anti-(T,G)- 
A- L anti- 
body 
No 
No 
No 
No 
Yes 
Serum 
dilu-  1~l-labeled anti-anotype  Production of 
reagents§  LR allotyp~  I 
tion$ 
Donor* 
Anti-  Anti-  Anti-  Anti-  Anti-(T,G)- 
Log  ~  1 ~  lb  4 ~  4~  A-L  anti- 
body 
CKB  ×  CSW F~ 
No. 2  1  2,556  8,657  2,081  3,562  Yes 
2  1,370  4,641  1,449  3,147 
3  798  2,465  942  2,352 
4  496  1,542  484  1,533 
No. 3  1  153  390  141  240  - 
2  123  198  108  132 
3  126  183  119  95 
4  105  174  94  72 
No. 4  1  4,127  6,761  1,980  3,048  Yes 
2  2,745  4,260  1,841  2,920 
3  1,476  2,274  1,549  2,541 
4  975  1,265  969  1,663 
No. 5  1  3,181  9,043  2,026  3,253  Yes 
2  2,052  5,382  2,004  2,836 
3  1,313  3,233  1,740  2,436 
4  850  1,791  1,059  1,741 
CKB 
No.  1  1  89  290  119  130 
No. 2  1  71  310  93  128 
No. 3  1  67  336  93  103 
CSW 
No. 1  i  5,830  175  1,998  124 
No. 2  I  8,076  267  2,164  161 
* Chimeric mice were immunized 8 wk after reconstitution with 10 pg (T,G)-A-L-52 i.p.  in CFA, challenged 1 mo later with I0 pg (T,G)-A- 
L i.p.  in PBS, and bled 8 days later.  F~, CKB, and CSW  mice immunized at  the same time. 
Starting serum dilution 1:100;  doubling dilutions thereaRer. 
§ Counts for anti-1  ~ and anti-1  ° are counts per minute; for anti-4  ~ and anti-4% counts per 0.4 rain. 20 ~l of  detecting reagent (anti-aUotype 
antibody) added per  well:  anti-1  b and anti-1  °,  26,836 and 9,530 counts/minute,  respectively;  anti-4  b  and anti-4  ~ each 20,000 counts/0.4 rain. 
II  LR (Iow-responder)  allotype anti-(T,G)-A-L  antibody production denoted as yes if  counts bound with anti-1  # or anti-4  b aye greater than 
those measured for CKB  controls. Dashed line indicates little  or no overall antibody production. 
Furthermore,  at  least  20%  of  either  Ig  allotype  can  be  detected  in  these 
mixtures.  For  example,  there  is  a  clear  distinction  in  the  counts  bound  of 
either anti-Ig-1 b or Ig-4 b antibody for the 80% Iga/20%  Ig  ~ mixture of (CSW  + 
CWB)  versus  (CSW  +  CKB).  When standard  curves are plotted as described 
above,  there  is  a  good  correlation  between  the  observed  and  expected  anti- 
allotype  counts  bound  in the  two mixtures  at  varying  Ig  allotype  ratios,  by 
using the serum dilutions which correspond to the linear portions of the curves. 
Table II shows the results obtained from the Ig allotype-specific analysis  of 
anti-(T,G)-A-L  antibody produced by five CKB ~  CSW chimeric mice. All of 
the chimeric mice had Ig of both Ig  a and Ig  b allotype in their preimmune sera 
by Ouchterlony gel diffusion analysis.  The plate assay was used to determine 
whether any of these chimeras made IgG1 or IgG2a anti-(T,G)-A-L  antibody of 
low-responder allotype  (Ig  b)  in  amounts  greater than  those produced  by low- 
responder CKB  mice.  Secondary sera from CKB,  CSW,  and  (CKB  x  CSW)F1 PRESS  AND  MCDEVITT  BRIEF  DEFINITIVE  REPORT  1819 
mice were included as  controls.  Four of five F~  mice made detectable anti- 
(T,G)-A-L antibody,  and these four produced antibody of low-responder Ig 
allotype (Ig  #) in amounts greater than the CKB control mice. Four of the five 
chimeric mice also made anti-(T,G)-A-L antibody, but none made antibody of 
Ig  b (low-responder) allotype in amounts greater than the CKB control mice. 
The  anti-(T,G)-A-L  antibody produced by  these  chimeras  was  of high-re- 
sponder strain Ig allotype (Ig~). 
Discussion 
Lymphoid cell chimerism and antigen-priming in the presence of both high 
and low responder strain H-2 antigens do not appear sufficient to overcome the 
genetic restrictions on cell interaction imposed by Ir-lA gene regulation. None 
of the  CKB  ~  CSW  chimeras  produced  anti-(T,G)-A-L  antibody  of low 
responder  strain  Ig  allotype  in  amounts  significantly  greater  than  those 
produced  by  control  low  responder  CKB  mice.  This  Ir-lA  gene-mediated 
restriction has also been observed in adoptive cell transfer studies with DNP- 
primed B cells from Ir-lA low responder BALB.K mice and (T,G)-A-L primed 
cells from either (BALB.B  ×  BALB.K)F~  or BALB.B  <-~ BALB.K  chimeric 
mice in  response to DNP-(T,G)-A-L  (9).  The chimeras used in this  study were 
not examined for their  ratios  of parental H-2 haplotypes. However, in other 
studies with BALB.B  ~  BALB.K  chimeras, the spleen cells  routinely have 
been 50:50  mixes of  both parental  H-2 haplotypes.  I  Since Ig  a and Ig  b  allotypes 
could be detected  in the CKB  ~-* CSW  chimeras' preimmune sera,  B cells  from 
both strains were apparently reconstituted. It could be argued that due to 
concomitant allotypic  as well  as  Ir-IA genetic  disparity,  there was insufficient 
repopulation by low responder T cells  and/or macrophages, hence the inability 
of  chimeric  low-responder B cells  to  be stimulated  by (T,G)-A-L. This argument 
would imply that chimeric low responder B cells  cannot interact  with chimeric 
histoincompatible high responder T cells  and macrophages in response to an 
antigen under Ir gene control. It is presumed that the production of high 
responder strain  Ig allotype  anti-(T,G)-A-L antibody by the chimeras is due 
to  the interaction  of  CSW  lymphoid cells,  and not endogenously repopulated FI 
cells,  but this  has not been directly  demonstrated. If  the stimulation of  chimeric 
high responder B cells  occurs via interactions  with FI cells,  then the results  of 
this  study are analogous to those  reported by Katz et al. (1). 
The results of this study differ  from the tetraparental mouse studies by 
Bechtel et al. (2, 3). Several of the original C3H <-* (CKB x CWB)FI tetraparen- 
tal anti-(T,G)-A-L-509 sera were therefore analyzed by the allotype-specific 
plate assay. None contained anti-(T,G)-A-L antibody of low responder strain 
Ig  a allotype in amounts greater than those detected in antisera of low responder 
C3H mice. However, some of the original (CWB x  C3H)F1 antisera also did not 
contain significant antibody levels of low responder Ig  a allotype, in contrast to 
the  (CKB  x  CSW)F~ control  mice  used  in  this  study.  The  tetraparental 
antisera were originally analyzed by absorption  onto  and acid elution from 
anti-Ig  ~ allotype-coupled Sepharose  (2,  3).  The  passed  and  eluted fractions 
were then analyzed by an antigen-specific, but not aUotype-specific Farr assay 
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(3). When the remaining acid eluted fractions of the tetraparental sera were 
analyzed by the allotype-specific plate assay,  antibody of high responder Ig  b 
allotype was detected in varying amounts, but little antibody of low responder 
Ig  a allotype was observed (J. Press, unpublished observations). Further studies 
of new chimeric and tetraparental mice will be required to resolve this paradox 
and clarify the mechanisms underlying Ir gene regulation. 
Received for publication 12 August 1977. 
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